Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer
- PMID: 19892859
- PMCID: PMC2817815
- DOI: 10.1164/rccm.200907-1064OC
Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer
Abstract
Rationale: Radiotherapy (RT) is considered the standard treatment for patients with stage I or II non-small lung cancer who are not surgical candidates because of comorbities or preferences against surgery.
Objectives: To compare the outcomes of patients treated with RT alone with those who were untreated to assess the effect of RT on survival.
Methods: Using the Surveillance, Epidemiology and End Results (SEER) registry linked to Medicare files, we identified 6,065 unresected patients with histologically confirmed stage I and stage II non-small cell lung cancer, diagnosed between 1992 and 2002. We used propensity score methods and instrumental variable analysis to control for the possible effects of known as well as unmeasured confounders.
Measurements and main results: Overall, 59% of patients received RT. The overall and lung cancer-specific survival of unresected patients treated with RT was significantly better compared with the untreated cases (P < 0.0001 for both comparisons). RT was associated with a 6-month improvement in median overall survival. Propensity score analyses showed that RT was associated with improved overall (hazard ratio, 0.74; 95% confidence interval, 0.70-0.78) and lung cancer-specific survival (hazard ratio, 0.73; 95% confidence interval, 0.69-0.78). Instrumental variable analysis also indicated improved outcomes among patients treated with RT.
Conclusions: RT improves survival of elderly patients with unresected stage I or II lung cancer. These results should be confirmed in prospective trials.
Figures


Comment in
-
Optimal therapy for elderly patients with early stage non-small cell lung cancer.Am J Respir Crit Care Med. 2010 Feb 1;181(3):201-2. doi: 10.1164/rccm.200910-1558ED. Am J Respir Crit Care Med. 2010. PMID: 20093653 No abstract available.
References
-
- Spiro SG, Porter JC. Lung cancer–where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002;166:1166–1196. - PubMed
-
- Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379–392. - PubMed
-
- National comprehensive cancer network. Practice guidelines in oncology. Lung cancer-v.1.2008. Available from: http://www.Nccn.Org/professionals/physician_gls/pdf/esophageal.Pdf. Accessed August 14, 2008.
-
- Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198–1205. - PubMed
-
- Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1–11. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical